Gómez-Foix A M, Rodríguez-Gil J E, Fillat C, Guinovart J J, Bosch F
Department of Biochemistry, Autonomous University of Barcelona, School of Veterinary Medicine, Spain.
Biochem J. 1988 Oct 15;255(2):507-12.
In rat hepatocytes, vanadate increases fructose 2,6-bisphosphate (Fru-2,6-P2) in a time- and dose-dependent manner, and counteracts the decrease in this metabolite caused by glucagon, forskolin or exogenous cyclic AMP. Vanadate does not directly modify the activity of 6-phosphofructo-2-kinase, even though it can counteract the inactivation of this enzyme caused by glucagon. Furthermore, vanadate raises the yield of 3H2O from [3-3H]glucose, indicating that it increases the flux through 6-phosphofructo-1-kinase. Moreover, vanadate in hepatocytes incubated in the presence of glucose increases the production of both lactate and CO2. Therefore vanadate has insulin-like effects on the glycolytic pathway in rat hepatocytes. These results clearly contrast with our previous observation that vanadate exerts glycogenolytic non-insulin-like effects on glycogen synthase and phosphorylase.
在大鼠肝细胞中,钒酸盐能以时间和剂量依赖的方式增加果糖2,6 -二磷酸(Fru - 2,6 - P2)的含量,并抵消由胰高血糖素、福斯可林或外源性环磷酸腺苷引起的该代谢物含量降低。钒酸盐不会直接改变6 -磷酸果糖 - 2 -激酶的活性,尽管它能够抵消由胰高血糖素导致的该酶失活。此外,钒酸盐能提高[3 - 3H]葡萄糖生成3H2O的产量,这表明它增加了通过6 -磷酸果糖 - 1 -激酶的通量。而且,在葡萄糖存在的情况下孵育的肝细胞中的钒酸盐会增加乳酸和二氧化碳的生成。因此,钒酸盐对大鼠肝细胞的糖酵解途径具有胰岛素样作用。这些结果与我们之前观察到的钒酸盐对糖原合酶和磷酸化酶发挥糖原分解的非胰岛素样作用形成了鲜明对比。